Research study examines Alzheimer's disease drug on tissue samples from people with Down syndrome

People with Down syndrome are likely to develop Alzheimer's disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid plaques. Yet people with Down syndrome have been excluded from or underrepresented in clinical trials of new therapies for treating AD.

from Top Health News -- ScienceDaily https://ift.tt/czYya9H